VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PTNPalatin Technologies, Inc.
$11.72$13M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

PTN logoPalatin Technologies, Inc.(PTN)Earnings, Financials & Key Ratios

PTN•AMEX
Price updated Jun 19, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCommercial Specialty Pharma
AboutPalatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.Show more
  • Revenue$0-100.0%
  • EBITDA-$17M+22.4%
  • Net Income-$17M+41.8%
  • EPS (Diluted)-32.15-1491.6%

PTN Key Insights

Palatin Technologies, Inc. (PTN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 99 (top 1%)
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 96.3% through buybacks
  • ✓Healthy 5Y average net margin of 3544.2%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when PTN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PTN Price & Volume

Palatin Technologies, Inc. (PTN) stock price & volume — 10-year historical chart

Loading chart...

PTN Growth Metrics

Palatin Technologies, Inc. (PTN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM3581.22%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM73.21%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-63.78%

Return on Capital

10 Years-273.76%
5 Years-396.73%
3 Years-721.49%
Last Year-

PTN Recent Earnings

Palatin Technologies, Inc. (PTN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (64%)●Beat Revenue 2/12 qtrs (40%)
Q2 2026Latest
May 13, 2026
Metric
Actual
Est
EPS
$0.37+70.2%
$1.24
Rev
$50,000-96.1%
$1M
Q1 2026
Feb 17, 2026
Metric
Actual
Est
EPS
$2.86-21.5%
$2.35
Rev
$116,036+364.1%
$25,000
Q4 2025
Nov 14, 2025
Metric
Actual
Est
EPS
$4.26
—
Rev
$9M
—
Q4 2025
Sep 23, 2025
Metric
Actual
Est
EPS
$4.14+56.4%
$9.50
Rev
—
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 13, 2026
$0.37vs $1.24+70.2%
$50,000vs $1M-96.1%
Q1 2026Feb 17, 2026
$2.86vs $2.35-21.5%
$116,036vs $25,000+364.1%
Q4 2025Nov 14, 2025
$4.26
$9M
Q4 2025Sep 23, 2025
$4.14vs $9.50+56.4%
—
Based on last 12 quarters of dataView full earnings history →

PTN Peer Comparison

Palatin Technologies, Inc. (PTN) competitors in Commercial Specialty Pharma — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
DARE logoDAREDaré Bioscience, Inc.Direct Competitor31.51M2.17-1.81104.29%-10.39%-471.37%0.93
EVAX logoEVAXEvaxion Biotech A/SProduct Competitor20.02M3.17-2.62125.12%-102.42%-61.46%0.44
PRGO logoPRGOPerrigo Company plcProduct Competitor1.42B10.25-1.00-2.75%-43.5%-50.65%1.35
ANIP logoANIPANI Pharmaceuticals, Inc.Product Competitor1.81B79.4923.9443.78%9.71%17.32%0.60
HIMS logoHIMSHims & Hers Health, Inc.Product Competitor7.79B35.4769.5559%-0.56%-2.48%2.34
INVA logoINVAInnoviva, Inc.Product Competitor1.66B22.496.8218.52%118.91%47.59%0.23
ABBV logoABBVAbbVie Inc.Supply Chain383.17B216.6391.418.57%6.91%62.15%
PFE logoPFEPfizer Inc.Supply Chain143.46B25.2218.54-1.65%11.83%8.34%0.78

Compare PTN vs Peers

Palatin Technologies, Inc. (PTN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DARE

Most directly comparable listed peer for PTN.

Scale Benchmark

vs LLY

Larger-name benchmark to compare PTN against a more recognizable public peer.

Peer Set

Compare Top 5

vs DARE, EVAX, PRGO, ANIP

PTN Income Statement

Palatin Technologies, Inc. (PTN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Sales/Revenue
44.72M67.13M60.3M117.99K-188.6K1.47M4.85M4.49M012.88M
Revenue Growth %
-50.11%-10.18%-99.8%-259.84%878.62%230.53%-7.49%-100%3581.22%
Cost of Goods Sold
45.68M32.57M14.86M0147.84K217.53K418.47K97.64K031.34K
COGS % of Revenue
102.14%48.51%24.64%--78.39%14.81%8.62%2.17%--
Gross Profit
-959.35K▲ 0%
34.57M▲ 3703.3%
45.44M▲ 31.5%
117.99K▼ 99.7%
-336.44K▼ 385.1%
1.25M▲ 471.8%
4.44M▲ 254.6%
4.39M▼ 1.0%
0▼ 100.0%
12.85M▲ 0%
Gross Margin %
-2.15%51.49%75.36%100%178.39%85.19%91.38%97.83%-99.76%
Gross Profit Growth %
-2128.34%3703.34%31.46%-99.74%-385.14%471.82%254.55%-0.96%-100%-
Operating Expenses
55.29M41.21M24.56M23.72M33.05M37.84M36.89M26.89M17.46M19.39M
OpEx % of Revenue
123.63%61.38%40.72%20107.61%-17522.9%2576.81%760.13%598.84%--
Selling, General & Admin
9.61M8.64M9.7M9.77M17.34M16.51M15.29M12.27M7.81M9.4M
SG&A % of Revenue
21.49%12.87%16.08%8276.51%-9192.57%1124.44%315.04%273.27%--
Research & Development
45.68M32.57M14.86M13.96M12.93M21.33M22.63M22.4M14.9M12.33M
R&D % of Revenue
102.14%48.51%24.64%11831.1%-6854.06%1452.37%466.26%498.88%--
Other Operating Expenses
00002.78M0-1.03M-7.78M-5.25M-1000K
Operating Income
-10.57M▲ 0%
25.93M▲ 345.3%
35.74M▲ 37.9%
-23.61M▼ 166.0%
-33.38M▼ 41.4%
-36.59M▼ 9.6%
-32.46M▲ 11.3%
-22.5M▲ 30.7%
-17.46M▲ 22.4%
-6.52M▲ 0%
Operating Margin %
-23.63%38.62%59.28%-20007.61%17701.29%-2491.63%-668.75%-501.02%--50.6%
Operating Income Growth %
78.54%345.3%37.87%-166.04%-41.42%-9.6%11.29%30.69%22.39%-
EBITDA
-10.54M25.98M35.8M-23.54M-33.33M-36.1M-32.17M-22.16M-17.2M-6.42M
EBITDA Margin %
-23.56%38.7%59.37%-19953.2%17674.18%-2458.53%-662.81%-493.47%--49.83%
EBITDA Growth %
78.59%346.6%37.79%-165.76%-41.59%-8.31%10.89%31.13%22.37%72.25%
D&A (Non-Cash Add-back)
33.05K56.57K58.63K64.2K51.12K486.02K288.33K339.07K258.92K98.72K
EBIT
-10.54M25.93M35.74M-22.41M-33.6M-36.17M-28.69M-29.72M-17.29M-6.46M
Net Interest Income
-2.29M-1.45M-417.56K-20.14K23.57K-29.68K-20.01K-17.11K-15.03K207.21K
Interest Income
000023.57K0000214.46K
Interest Expense
2.29M1.45M417.56K20.14K029.68K20.01K17.11K15.03K7.25K
Other Income/Expense
-2.26M-1.14M28.71K1.18M-212.39K390.15K3.75M-7.24M152.59K270.13K
Pretax Income
-12.83M▲ 0%
24.79M▲ 293.2%
35.77M▲ 44.3%
-22.43M▼ 162.7%
-33.6M▼ 49.8%
-36.2M▼ 7.7%
-28.71M▲ 20.7%
-29.74M▼ 3.6%
-17.31M▲ 41.8%
-6.25M▲ 0%
Pretax Margin %
-28.69%36.92%59.32%-19006.88%17813.91%-2465.06%-591.55%-662.26%--48.5%
Income Tax
500K82.5K0000-4.67M000
Effective Tax Rate %
-3.9%0.33%0%0%0%0%16.28%0%0%0%
Net Income
-13.33M▲ 0%
24.7M▲ 285.3%
35.77M▲ 44.8%
-22.43M▼ 162.7%
-33.57M▼ 49.7%
-36.2M▼ 7.8%
-24.04M▲ 33.6%
-29.74M▼ 23.7%
-17.31M▲ 41.8%
-6.25M▲ 0%
Net Margin %
-29.81%36.8%59.32%-19006.88%17799.23%-2465.06%-495.23%-662.26%--48.5%
Net Income Growth %
74.22%285.3%44.81%-162.69%-49.69%-7.83%33.6%-23.71%41.8%73.21%
Net Income (Continuing)
-13.33M24.7M35.77M-22.43M-33.6M-36.2M-24.04M-29.74M-17.31M-6.25M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-1.81▲ 0%
2.98▲ 264.6%
4.12▲ 38.3%
-2.38▼ 157.8%
-3.55▼ 49.2%
-3.79▼ 6.8%
-2.21▲ 41.7%
-2.02▲ 8.6%
-32.15▼ 1491.6%
-5.69▲ 0%
EPS Growth %
78.09%264.64%38.26%-157.77%-49.16%-6.76%41.69%8.6%-1491.58%-63.78%
EPS (Basic)
-1.813.124.31-2.38-3.55-3.79-2.21-2.02-32.15-
Diluted Shares Outstanding
7.36M8.28M8.69M9.39M9.47M9.54M10.89M14.7M538.35K1.1M
Basic Shares Outstanding
7.36M7.92M8.31M9.39M9.47M9.54M10.89M14.7M538.35K971.65K
Dividend Payout Ratio
----------

PTN Balance Sheet

Palatin Technologies, Inc. (PTN) balance sheet — assets, liabilities & shareholders' equity

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Total Current Assets
56.58M38.51M104.41M83.59M65.91M34.6M16.32M9.77M2.92M12.79M
Cash & Short-Term Investments
40.45M38M43.51M82.85M60.1M29.94M10.98M9.53M2.56M10.16M
Cash Only
40.2M38M43.51M82.85M60.1M29.94M7.99M9.53M2.56M10.16M
Short-Term Investments
249.84K000002.99M000
Accounts Receivable
15.12M060.27M01.58M1.78M2.92M029.47K2.17M
Days Sales Outstanding
123.37-364.79--3.06K442.44219.27--76.06
Inventory
840.03K0149.74K01.16M944.47K526K000
Days Inventory Outstanding
6.71-3.68-2.87K1.58K458.79---
Other Current Assets
171.19K325.09K487.55K609.85K2.35M1.12M1.08M147.25K325.69K458.54K
Total Non-Current Assets
255.07K502.95K321.45K1.46M1.39M1.47M1.62M972.6K347.53K440.09K
Property, Plant & Equipment
198.15K164.03K141.54K1.41M1.33M1.42M1.56M915.68K290.61K418.46K
Fixed Asset Turnover
225.70x409.27x426.03x0.08x-0.14x1.04x3.11x4.90x-36.44x
Goodwill
0000000000
Intangible Assets
0000000000
Long-Term Investments
0000000000
Other Non-Current Assets
56.92K338.92K179.92K56.92K56.92K56.92K56.92K56.92K56.92K21.63K
Total Assets
56.83M▲ 0%
39.02M▼ 31.3%
104.74M▲ 168.4%
85.05M▼ 18.8%
67.3M▼ 20.9%
36.07M▼ 46.4%
17.94M▼ 50.3%
10.74M▼ 40.1%
3.27M▼ 69.6%
13.23M▲ 0%
Asset Turnover
0.79x1.72x0.58x0.00x-0.00x0.04x0.27x0.42x-1.20x
Asset Growth %
414.25%-31.35%168.44%-18.79%-20.88%-46.4%-50.27%-40.12%-69.59%653.32%
Total Current Liabilities
54.96M10.76M4.19M3.93M10.51M16.26M15.13M9.66M8.01M2.54M
Accounts Payable
1.55M2.22M504.79K715.67K640.65K3.16M4.3M4.1M7M1.69M
Days Payables Outstanding
12.424.9212.4-1.58K5.3K3.75K15.33K-62.75K
Short-Term Debt
7.82M5.95M332.9K0000000
Deferred Revenue (Current)
35.05M500M2.85M0000000
Other Current Liabilities
0487.49K499.52K03.72M7.3M5.42M2.72M00
Current Ratio
1.03x3.58x24.94x21.28x6.27x2.13x1.08x1.01x0.36x5.04x
Quick Ratio
1.01x3.58x24.91x21.28x6.16x2.07x1.04x1.01x0.36x5.04x
Cash Conversion Cycle
117.69-356.07--1.77K-3.27K-3.08K---62.67K
Total Non-Current Liabilities
7.04M1.29M0953.35K7.13M3.54M4.79M1.2M33.97K97.46K
Long-Term Debt
6.28M332.9K00000000
Capital Lease Obligations
000953.35K900.52K681.8K590.34K163.78K33.97K260.49K
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
753.96K456.04K006.23M2.86M4.2M1.03M00
Total Liabilities
62M12.05M4.19M4.88M17.65M19.8M19.92M10.85M8.04M2.63M
Total Debt
14.12M6.28M332.9K1.27M1.25M1.15M1.05M590.34K163.78K286.66K
Net Debt
-26.08M-31.72M-43.18M-81.59M-58.85M-28.79M-6.94M-8.94M-2.4M-9.87M
Debt / Equity
-0.23x0.00x0.02x0.03x0.07x---0.03x
Debt / EBITDA
-0.24x0.01x-------0.04x
Net Debt / EBITDA
--1.22x-1.21x------1.54x
Interest Coverage
-4.61x17.86x85.60x-1112.45x--1218.54x-1433.65x-1736.53x-1150.90x-889.91x
Total Equity
-5.16M▲ 0%
26.96M▲ 622.1%
100.55M▲ 272.9%
80.17M▼ 20.3%
49.65M▼ 38.1%
16.27M▼ 67.2%
-1.98M▼ 112.2%
-111.5K▲ 94.4%
-4.78M▼ 4184.5%
10.59M▲ 0%
Equity Growth %
70.63%622.11%272.89%-20.27%-38.07%-67.24%-112.17%94.37%-4184.46%-3533.78%
Book Value per Share
-0.703.2611.588.545.251.70-0.18-0.01-8.879.64
Total Shareholders' Equity
-5.16M26.96M100.55M80.17M49.65M16.27M-1.98M-111.5K-4.78M10.59M
Common Stock
1.61M2.01M2.27M2.29M92.02K92.71K116.57K179.27K9.3K17.76K
Retained Earnings
-356.74M-332.05M-295.77M-318.2M-351.8M-387.99M-412.03M-441.77M-459.07M-463.09M
Treasury Stock
0000000000
Accumulated OCI
-590-2.34M00000000
Minority Interest
0000000000

PTN Cash Flow Statement

Palatin Technologies, Inc. (PTN) cash flow — operating, investing & free cash flow history

MetricJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Cash from Operations
12.88M1.7M-21.78M41.33M-22.65M-29.92M-28.42M-31.46M-21.31M-14.93M
Operating CF Margin %
28.8%2.54%-36.12%35025.65%12008.67%-2037.7%-585.51%-700.69%--
Operating CF Growth %
127.2%-86.78%-1379.01%289.72%-154.8%-32.12%5.03%-10.71%32.28%132.08%
Net Income
-13.33M24.7M35.77M-22.43M-33.6M-36.2M-27.54M-29.74M-17.31M-6.25M
Depreciation & Amortization
33.05K56.57K58.63K64.2K51.12K126.67K288.33K339.07K258.92K98.72K
Stock-Based Compensation
1.76M3.52M3.48M3.14M3.17M2.51M1.41M1.87M1.38M815.06K
Deferred Taxes
0-500K00212.53K0-392.27K000
Other Non-Cash Items
298.79K175.49K51.23K299K19.42M203.92K166.26K-530.25K-4.88M-5.46M
Working Capital Changes
24.12M-26.25M-61.15M60.25M-11.9M3.44M-2.35M-3.41M-758.79K-4.14M
Change in Receivables
-15.12M15.12M-60.27M60.27M-1.58M-199.58K-1.14M2.92M-29.47K-1.9M
Change in Inventory
3.04M-7.68M781.07K0-987.24K217.53K418.47K-1.15M00
Change in Payables
837.48K672.33K-1.72M210.88K-75.02K2.57M1.11M-201.6K2.9M-2.33M
Cash from Investing
991.6K227.55K-36.14K-62.88K-5.72K-261.37K-3.43M12.45M3.13M578.7K
Capital Expenditures
-133.4K-22.45K-36.14K-62.88K-5.72K-261.37K-433.93K-42.53K0-51.3K
CapEx % of Revenue
0.3%0.03%0.06%53.29%-3.03%17.8%8.94%0.95%-0.4%
Acquisitions
00000009.5M00
Investments
----------
Other Investing
1.13M250K0000003.13M630K
Cash from Financing
18.32M-4.13M27.33M-1.92M-93.64K18.36K9.9M20.55M11.21M21.99M
Debt Issued (Net)
-5.69M-8.01M-6.5M-832.85K0-56.46K-100.92K-106.39K-46.01K0
Equity Issued (Net)
23.86M1.26M33.14M1.58M-93.64K-221.31K10.14M14.67M7.96M22.01M
Dividends Paid
0000000000
Share Repurchases
0000-93.64K-221.31K0000
Other Financing
161.65K2.63M693.17K-2.67M0296.13K-145.98K5.99M3.3M-19.51K
Net Change in Cash
32.2M▲ 0%
-2.2M▼ 106.8%
5.51M▲ 350.4%
39.34M▲ 614.0%
-22.75M▼ 157.8%
-30.17M▼ 32.6%
-21.95M▲ 27.2%
1.54M▲ 107.0%
-6.96M▼ 552.8%
7.64M▲ 0%
Free Cash Flow
12.75M▲ 0%
1.68M▼ 86.8%
-21.82M▼ 1398.2%
41.26M▲ 289.1%
-22.65M▼ 154.9%
-30.18M▼ 33.2%
-28.85M▲ 4.4%
-31.5M▼ 9.2%
-21.31M▲ 32.4%
-14.98M▲ 0%
FCF Margin %
28.5%2.5%-36.18%34972.36%12011.7%-2055.5%-594.45%-701.63%--116.29%
FCF Growth %
126.91%-86.82%-1398.24%289.12%-154.9%-33.24%4.41%-9.19%32.37%36.76%
FCF per Share
1.730.20-2.514.40-2.39-3.16-2.65-2.14-39.58-13.64
FCF Conversion (FCF/Net Income)
-0.97x0.07x-0.61x-1.84x0.67x0.83x1.18x1.06x1.23x2.40x
Interest Paid
01.08M019.22K000015.03K3.49K
Taxes Paid
0500K00000000

PTN Key Ratios

Palatin Technologies, Inc. (PTN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-226.63%56.11%-24.82%-51.71%-109.83%-336.46%---141.4%
Return on Invested Capital (ROIC)
--101.9%-63.28%-----198.27%
Gross Margin
-2.15%51.49%75.36%100%178.39%85.19%91.38%97.83%-99.76%
Net Margin
-29.81%36.8%59.32%-19006.88%17799.23%-2465.06%-495.23%-662.26%--48.5%
Debt / Equity
-0.23x0.00x0.02x0.03x0.07x---0.03x
Interest Coverage
-4.61x17.86x85.60x-1112.45x--1218.54x-1433.65x-1736.53x-1150.90x-889.91x
FCF Conversion
-0.97x0.07x-0.61x-1.84x0.67x0.83x1.18x1.06x1.23x2.40x
Revenue Growth
-50.11%-10.18%-99.8%-259.84%878.62%230.53%-7.49%-100%3581.22%
Related:PTN Dividend History·PTN Revenue History·PTN Price History·PTN P/E History·PTN Financial Ratios·PTN Institutional Holders

PTN SEC Filings & Documents

Palatin Technologies, Inc. (PTN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 18, 2026·SEC

Material company update

Nov 12, 2025·SEC

Material company update

Nov 6, 2025·SEC

10-K Annual Reports

3
FY 2025

Sep 23, 2025·SEC

FY 2024

Sep 30, 2024·SEC

FY 2023

Sep 28, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

May 13, 2026·SEC

FY 2026

Feb 17, 2026·SEC

FY 2025

Nov 14, 2025·SEC

PTN Frequently Asked Questions

Palatin Technologies, Inc. (PTN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Palatin Technologies, Inc. (PTN) reported $12.9M in revenue for fiscal year 2025. This represents a 64321% increase from $0.0M in 1996.

Palatin Technologies, Inc. (PTN) saw revenue decline by 100.0% over the past year.

Palatin Technologies, Inc. (PTN) reported a net loss of $6.2M for fiscal year 2025.

Dividend & Returns

Palatin Technologies, Inc. (PTN) had negative free cash flow of $15.0M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in PTN back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in PTN be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →